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EXPERIMENTAL STUDIES
Quantification of Renal Blood Flow
With Contrast-Enhanced Ultrasound
Kevin Wei, MD, FACC,*† Elizabeth Le, MD,*† Jian-Ping Bin, MD,* Matthew Coggins, BA,*
Jerrel Thorpe, RDCS,*† Sanjiv Kaul, MD, FACC*†
Charlottesville, Virginia
OBJECTIVES The goal of this study was to determine the ability of contrast-enhanced ultrasound (CEU)
to quantify renal tissue perfusion.
BACKGROUND The kinetics of tracers used to assess renal perfusion are often complicated by countercurrent
exchange, tubular transport or glomerular filtration. We hypothesized that, because gas-filled
microbubbles are pure intravascular tracers with a rheology similar to that of red blood cells,
CEU could be used to quantify renal tissue perfusion.
METHODS During a continuous venous infusion of microbubbles (SonoVue), regional renal perfusion
was quantified in nine dogs using CEU by destroying microbubbles and measuring their
tissue replenishment with intermittent harmonic imaging. Both renal blood volume fraction
and microbubble velocity were derived from pulsing-interval versus video-intensity plots. The
product of the two was used to calculate renal nutrient blood flow. Renal arterial blood flow
was independently measured with ultrasonic flow probes placed directly on the renal artery
and was increased using dopamine and decreased by placement of a renal artery stenosis.
RESULTS An excellent correlation was found between cortical nutrient blood flow using microbubbles
and ultrasonic flow probe-derived renal blood flow (r 5 0.82, p , 0.001) over a wide range
(2.5 fold) of flows.
CONCLUSIONS Ultrasound examination during microbubble infusion can be used to quantify total organ as
well as regional nutrient blood flow to the kidney. (J Am Coll Cardiol 2001;37:1135– 40)
© 2001 by the American College of Cardiology
The kidney is a complex structure involved in the excretion
of metabolic waste products as well as the regulation of fluid
volume, osmolarity and acid base status. These functions are
influenced in large part by alterations in the regional
distribution of blood flow between the renal cortex and
medulla. The ability to accurately measure such variations in
regional renal perfusion could provide important clinical
insights into renal function.
Color and spectral Doppler are currently commonly used
methods to assess renal perfusion noninvasively (1). These
methods provide an assessment of only renal arterial blood
flow (RBF) without any information on actual tissue nutri-
ent blood flow (NBF). There are several disease states where
regional NBF can be abnormal without significantly affect-
ing RBF and vice versa. Currently used methods for
quantifying regional renal NBF have significant limitations:
they are either invasive, rely on the use of tracers that are
diffusible or have kinetics that are complicated by tubular
transport or glomerular filtration (2,3).
Contrast-enhanced ultrasound (CEU) uses gas-filled mi-
crobubbles as a tracer to assess tissue perfusion with ultra-
sound. Because these microbubbles remain entirely within
the intravascular space (4) and have a rheology similar to
that of red blood cells (4,5), we hypothesized that measure-
ments of their renal tissue kinetics could be used to quantify
RBF as well as renal NBF. We have previously shown that,
at steady state during a continuous infusion, measuring the
rate at which microbubbles replenish tissue after their
destruction provides an assessment of tissue microbubble
velocity (6). When the tissue has been completely replen-
ished with microbubbles, the signal from the microbubbles
reflects tissue blood volume fraction (BVF) (6). The product
of microbubble velocity and BVF reflects NBF (6). In this
study, we evaluated the ability of this method to quantify
regional renal NBF in a canine model.
METHODS
Animal preparation. The study was approved by the An-
imal Research Committee at the University of Virginia and
conformed to the American Heart Association Guidelines
for use of animals in research. After induction of anesthesia
with 30 mg/kg21 sodium pentobarbital (Abbott Laborato-
ries, Abbott Park, Illinois), nine dogs were intubated and
ventilated with a respirator pump (model 607, Harvard
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Apparatus, South Natick, Massachusetts). Additional anes-
thesia was administered during the study as required. Both
femoral veins were exposed and cannulated with 7F cathe-
ters for administration of microbubbles, fluids and drugs. A
7F catheter was placed in the femoral artery for continuous
measurement of arterial pressure. An incision was made in
the left flank to expose the left kidney and its vascular
supply. A custom-designed screw occluder and an ultrasonic
time-of-flight flow probe (series SB, Transonics, Ithaca,
New York) were placed around the renal artery.
The flow probe was connected to a digital flow meter
(model T206, Transonics). The femoral arterial catheter
(connected to a fluid-filled pressure transducer) and flow
meter were connected to a multichannel recorder (model
ES2000, Gould Electronics, Valley View, Ohio). Mean
RBF and central arterial pressure were acquired digitally
into a personal computer via an analog-to-digital converter
(Metrabyte Corp., Taunton, Massachusetts). The signals
were also displayed on-line using Labtech notebook (Lab-
oratory Technologies Corp., Wilmington, Massachusetts).
CEU. Two milliliters of SonoVue (Bracco Diagnostics,
Princeton, New Jersey) were diluted to a total volume of
50 mL and infused at approximately 100 mL/h21 via the
femoral catheter (7). When required, the infusion rate was
adjusted to produce adequate renal opacification without
attenuation of far-field structures.
Contrast-enhanced ultrasound was performed with a
phased array system (HDI 5000, Advanced Technology
Laboratories, Bothell, Washington) using transmit and
receive frequencies of 1.66 and 3.3 MHz, respectively. The
transmit power and compression were set at maximum.
Gain settings were optimized at the beginning of each study
and were then held constant. A saline bath acted as an
acoustic interface between the transducer and the kidney.
Ultrasound transmission was gated to the electrocardiogram
and was progressively increased from a pulsing interval (PI)
of 80 ms to 20 s. Up to eight images were acquired at each
PI and were recorded on 1.25 cm S-VHS videotape (Pana-
sonic AG-MD830, Matsushita Corp., Osaka, Japan) for
later analysis.
Data were transferred from videotape to an off-line
computer in a 320 3 240 3 8 bit format and analyzed using
custom-designed software as previously described (8). At
least five images acquired at baseline (pre-contrast) and at
each PI were aligned using computer cross-correlation.
Regions-of-interest were placed over the cortex and medulla
of the kidney (Fig. 1). The cortex was identified by its
echogenicity compared with the less echogenic medulla.
The arcuate arteries, which separate the two regions, could
be distinguished from renal parenchyma because the high
blood flow velocity in these vessels allowed them to be
opacified with microbubbles even during real-time imaging
(PI 5 33 ms). Care was taken to exclude the interlobar and
arcuate arteries from the regions-of-interest. Video intensity
(VI) in both regions were automatically measured from each
aligned image and then background-subtracted. The result-
ing background-subtracted VI values from images at each
PI were then averaged. Pulsing interval versus background-
subtracted VI plots were generated and fitted to an expo-
nential function: y 5 A(12e2bt), where y is VI at PI of t, A
is the plateau VI representing BVF, and b represents mean
microbubble velocity. Nutrient blood flow was calculated by
multiplying A by b (6).
In addition to the above analyses, color-coding was
applied to averaged background-subtracted images to visu-
ally enhance regional differences in VI (8). The VI scale was
first expanded to a dynamic range of 128 gray levels, where
the pixel showing the greatest change was assigned a value
of 128, and all other pixels were assigned proportionally
lower values. All pixels with a gray scale value of .10 were
then assigned a color based on the degree of contrast
enhancement, where shades of red, progressing to hues of
Abbreviations and Acronyms
BVF 5 blood volume fraction
CEU 5 contrast-enhanced ultrasound
NBF 5 nutrient blood flow
PI 5 pulsing interval
RBF 5 renal arterial blood flow
VI 5 video intensity
Figure 1. Gray-scale image of the kidney from an animal showing distinct
differences in echogenicity between the cortex and medulla (A). (B) The
location of regions-of-interest drawn over the cortex (blue) and medulla
(green) to derive regional video intensity measurements. See text for
details.
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orange, yellow and then white represent incremental con-
trast opacification. Pixels with values #10 were considered
to represent noise and were not assigned any color (8).
Protocol. In each dog, CEU was performed at baseline,
and, after total RBF was either reduced with a flow-limiting
renal artery stenosis or increased with an intravenous infu-
sion of dopamine (2.5 to 5 mg/kg21zmin21). Hemodynamic
variables were acquired at each stage.
Observer variability. Inter- and intra-observer variability
were obtained by analysis of 12 random stages in dogs by
two independent blinded observers and by the same ob-
server at two different time points.
Statistical analysis. Data are expressed as mean 6 stan-
dard deviation. Comparisons between two stages were
performed using Student’s t test, while those between .2
stages were made using repeated measures analysis of
variance. Correlations were obtained using least squares fit
linear regression analysis. Differences were considered sig-
nificant at p , 0.05 (two-sided).
RESULTS
No significant differences were seen in mean aortic pressure
or heart rate between baseline, stenosis and dopamine
stages. At baseline, total RBF was 97 6 26 mL/min21 and,
as expected, it decreased during placement of a flow-
limiting stenosis on the renal artery (to 52 6 30 mL/min21)
and increased with the infusion of low-dose dopamine (to
125 6 20 mL/min21). These changes in total RBF were
highly significant (p , 0.001).
Because .90% of total RBF entering the kidney supplies
the renal cortex (3), change in cortical microbubble velocity
was used as a surrogate for alteration in total RBF. Changes
in total RBF were mirrored by changes in cortical micro-
bubble velocity during CEU. It was 0.8 6 0.2 s21 at
baseline and changed to 0.6 6 0.3 s21 and 1.5 6 0.3 s21
during coronary stenosis and dopamine infusion, respec-
tively (p , 0.001). An excellent correlation was found
between ultrasonic flow probe-derived RBF versus micro-
bubble velocity (r 5 0.82, p , 0.001, SEE 5 0.30).
Background-subtracted color-coded images obtained at
three different PI, and the corresponding PI versus VI
curves obtained from one dog at baseline and during
infusion of dopamine are shown in Figure 2. Total RBF in
this dog increased from 103 to 120 mL/min21 during
dopamine. A progressive increase in renal cortical VI is seen
as the PI is increased from 1,016 ms (Fig. 2A) to 5,080 ms
(Fig. 2B) to 15,000 ms (Fig. 2C). Brighter hues of orange
and yellow are seen in the cortex at the shorter PIs during
dopamine compared with the corresponding PI at baseline,
indicating greater degrees of microbubble replenishment for
each PI during dopamine infusion. Consequently, the rate
of rise of VI is correspondingly higher (Fig. 2D) during
dopamine on the PI versus VI curve (open circles) compared
Figure 2. Background-subtracted color-coded images obtained from an animal at progressively longer pulsing intervals (A to C), both at baseline and during
infusion of dopamine. The corresponding pulsing interval versus video intensity curves from the cortex at both stages are shown in D. See text for details.
1137JACC Vol. 37, No. 4, 2001 Wei et al.
March 15, 2001:1135–40 Noninvasive Measurement of Regional Renal Blood Flow
with baseline (closed circles) and was reflected by an
increase in microbubble velocity from 0.7 to 1.7 s21.
Background-subtracted color-coded images obtained at
three different PI and the corresponding PI versus VI curves
obtained from another dog at baseline and during a decrease
in total RBF from 58 to 6 mL/min21 after placement of a
critical renal artery stenosis are shown in Figure 3. In the
presence of a stenosis, a small change in cortical micro-
bubble enhancement is seen as the PI was increased from
Figure 3A to C, but the degree of enhancement is lower at
all PI compared with baseline. The lower rate of rise of VI
(open vs. closed circles) was reflected by a significant
decrease in cortical microbubble velocity from 0.8 to 0.2 s21
(Fig. 3D).
Observer variability. The inter- and intra-observer vari-
ability for the values A and b derived from VI versus PI
curves from 12 separate random stages were excellent. They
were: r 5 0.88, p , 0.01 and r 5 0.91, p , 0.01 for A, r 5
0.91, p , 0.01 and r 5 0.92 (p , 0.01) for b, respectively.
DISCUSSION
In this study, we have shown that the method of micro-
bubble destruction and replenishment can be used to mea-
sure absolute RBF. The technique is easy to perform, robust
and noninvasive. Therefore, this method could provide very
useful information regarding renal tissue perfusion in indi-
vidual patients, particularly when coupled with Doppler.
Together, these ultrasound methods could be used for
routine noninvasive examination of the macro- and micro-
vascular compartments of the kidney. In addition, they
could provide unique insights on the effects of various
interventions on total RBF as well as regional renal NBF.
Comparison of CEU with other methods of measuring
renal NBF. Many techniques have been developed over the
years in an attempt to quantify regional renal NBF. These
include: regional washout of hydrogen or inert gases, heat
diffusion, isotope trapping, radiolabeled microspheres, laser
Doppler flow, computed tomography, magnetic resonance
imaging and positron emission tomography (2,3). Many of
these methods have limited clinical applicability because of
their invasive nature or their limited availability. Others
pose methodologic problems because the tracers themselves
produce hemodynamic effects or are subject to tubular
transport or glomerular filtration (2,3). Some tracers cannot
be used simultaneously to assess both total RBF and
regional renal NBF (3).
Microbubbles used with CEU are not subject to many of
these limitations because they are hemodynamically inert
and have a rheology similar to that of red blood cells (4,5).
They are also small and uniform in size, and, therefore, not
as prone to axial streaming or geometric exclusion as has
been reported with the larger radiolabeled microspheres
(9,10), which, in any case, cannot be used for assessing renal
NBF in humans. Furthermore, the microbubbles remain
Figure 3. Background-subtracted color-coded images obtained from an animal at progressively longer pulsing intervals (A to C), at baseline and in the
presence of a flow-limiting renal artery stenosis. The pulsing interval versus video intensity curves obtained from the cortex during both stages are shown
in D. See text for details.
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entirely intravascular, and, consequently, are not affected by
glomerular filtration or tubular transport. Unlike many
other techniques, repeated measurements of regional renal
NBF can also be performed with CEU, as the microbubbles
are rapidly cleared from the circulation after their adminis-
tration. Additionally, ultrasound can provide simultaneous
information regarding kidney size and structure.
Earlier attempts to quantify renal perfusion using CEU
employed the use of direct intraarterial injections of air-
filled microbubbles (11,12). The transit time of the micro-
bubbles through the kidney could be measured, and total
flow per unit volume could be quantified using classic
indicator dilution curve theory. Although successful, this
approach was invasive. Furthermore, unlike our method,
absolute tissue flow could not be determined.
As shown by our results, CEU can be used to determine
changes in total RBF. Because .90% of blood flow entering
the kidney supplies the renal cortex (3), changes in cortical
blood flow were compared with ultrasonic flow probe
derived total RBF. Similar to the results from previous
studies (13,14), infusions of low-dose dopamine resulted in
increases in total RBF without affecting hemodynamic
variables such as heart rate or blood pressure. In the absence
of such changes in renal perfusion pressure with dopamine,
no significant increase in renal cortical BVF would be
expected. Thus, increases in RBF were reflected solely by
increases in microbubble velocity. After total RBF was
reduced with flow limiting stenoses, significant decreases in
microbubble velocity were found. As shown in Figure 2,
plateau VI was lower in the presence of a critical stenosis
compared with baseline. This finding is in agreement with
previous studies showing that reductions in renal perfusion
pressure below the lower limit of autoregulation result in a
dramatic decline in cortical BVF (15).
Detection of renal artery stenosis. One of the common
conditions for which ultrasound examination of the kidney
is performed is renal artery stenosis. As stated earlier,
Doppler is currently used for this purpose. One of the main
limitations with Doppler is inaccurate identification of the
renal arteries, which can be exacerbated by anatomic varia-
tions such as the presence of multiple arteries. Identification
of the renal artery is also tedious and time-consuming.
Furthermore, correct estimation of renal artery stenosis
severity from peak systolic velocity measurements requires
that the angle of interrogation be parallel to the vessel,
which is not always possible. Unlike Doppler, CEU does
not require identification of the renal artery, nor is it
angle-dependent.
Because a nonflow limiting stenosis does not affect resting
RBF, its detection generally requires the use of some
pharmacologic “stress,” such as captopril (16). It has been
shown, however, that even within the autoregulatory range,
reductions in renal perfusion pressure are associated with
decreases in cortical NBF without changes in medullary
NBF (17). Thus, determining the ratio of cortical versus
medullary NBF with CEU could potentially be used to
determine the presence of nonflow limiting renal artery
stenosis, even without recourse to a pharmacological ma-
neuver.
Study limitations. One of the limitations of CEU is
shadowing produced by microbubbles. Those nearest to the
ultrasound probe act as a shield, thus preventing penetration
of ultrasound to deeper structures. This artifact can be
precluded by decreasing the microbubble infusion rate so
that homogeneous opacification is produced even at long PI.
Another common problem relates to lack of a homogenous
ultrasound field, especially in a phased-array transducer,
which was used for our study (18). Because the ultrasound
energy falls off by the cosine of the angle from the center of
the beam, less backscatter is noted in the lateral aspects of
the sector. This can be overcome by using a linear-array
transducer, which, in any case, is the preferred transducer
for renal imaging. Despite the reduction in signal from the
lateral aspects and the apparent reduction in plateau VI,
however, the microbubble velocity will still be the same,
which indicates that one is dealing with an artifact rather
than an actual perfusion defect.
Conclusions. We have described a new method for mea-
suring RBF and renal NBF noninvasively using ultrasound.
The method is simple and easy to perform. Important and
useful information can be obtained in a very short time.
Repeated measurements can be performed to assess changes
in RBF as well as renal NBF. The method has great
potential for assessing patients with known or suspected
renal disease. It also has potential for assessing NBF to
other organs accessible to ultrasound.
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